376478000: Basiliximab 20mg/vial powder (product)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1201791017 Basiliximab 20mg/vial powder (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1214760015 Basiliximab 20mg/vial powder en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

1201791017 Basiliximab 20mg/vial powder (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1201791017 Basiliximab 20mg/vial powder (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1214760015 Basiliximab 20mg/vial powder en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1214760015 Basiliximab 20mg/vial powder en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Basiliximab 20mg/vial powder	Is a	Product containing monoclonal antibody (product)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Basiliximab 20mg/vial powder	Is a	Murine-human monoclonal IgG antibody (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Basiliximab 20mg/vial powder	Is a	Product containing basiliximab (medicinal product)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Basiliximab 20mg/vial powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Basiliximab	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Basiliximab 20mg/vial powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Monoclonal antibody	false	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Concept inactivation indicator attribute value reference set (foundation metadata concept)

POSSIBLY EQUIVALENT TO association reference set

SAME AS association reference set (foundation metadata concept)